In
The News

In The News

With more positive data for Covid-19 vaccine candidate, Altimmune prepares to start clinical trials
October 12, 2020
Source
Washington Business Journal
Inhaled Vaccines Aim to Fight Coronavirus at Its Point of Attack – Vaccines sprayed into the nose or inhaled through the mouth won’t require needles and could be easier to roll out. They may be more effective too.
October 11, 2020
Source
Bloomberg News
Closing Bell: Altimmune CEO on Covid-19 vaccine and treatment, which involves a nasal spray
August 11, 2020
Source
CNBC
Altimmune CEO on the biotech’s Covid-19 strategy, vaccine development
August 10, 2020
Source
Washington Business Journal
Altimmune making headway with Covid-19 programs
July 13, 2020
Source
Washington Business Journal
Altimmune COVID-19 vaccine candidate tested at UAB shows positive results
July 13, 2020
Source
WBRC
Covid-19 vaccine trial involving UAB shows promising results
July 13, 2020
Source
Birmingham Business Journal
Altimmune Inc. (NASDAQ:ALT) Receives IND Approval From The FDA for Phase II HepTcell Study In HBV
July 10, 2020
Source
BioPharma Journal
Altimmune partners with DynPort on intranasal Covid-19 vaccine
July 10, 2020
Source
PharmaTech
Altimmune teams up with DynPort to assist in COVID-19 vaccine funding
July 9, 2020
Source
Seeking Alpha
Altimmune Signs Teaming Agreement with DynPort Vaccine Company on U.S. Government Funding Efforts for its COVID-19 Vaccine Candidate, AdCOVID™
July 9, 2020
Source
BioSpace
Altimmune: Waiting For Their Next Move Against COVID-19
June 16, 2020
Source
Seeking Alpha
Altimmune signs WHO statement supporting collaboration on COVID-19 vaccine development
April 13, 2020
The race to develop a coronavirus vaccine
April 13, 2020
UAB to test COVID-19 vaccine candidate
March 30, 2020
Source
Birmingham Business Journal
Biopharma's no-holds-barred fight to find a COVID-19 vaccine: The full list [Altimmune Included]
March 20, 2020
Source
FierceBiothech
Top 60 COVID-19 treatments in development
March 19, 2020
Source
GEN News
Coronavirus/COVID-19 Vaccine Insights from Altimmune’s Leadership Team
March 18, 2020
Source
BioBuzz
Altimmune Becomes The Second Maryland-Based Biotech to Advance Potential Coronavirus/COVID-19 Vaccine
March 11, 2020
Source
BioBuzz
Altimmune Expands in Gaithersburg
August 24, 2017
Source
WDVM
Biotechnology Company Expands Headquarters In Gaithersburg, Plans 45 New Jobs
August 22, 2017
Source
Montgomery County Economic Development Corporation Maryland
Maryland Tech Council Announces Finalists for 29th Annual Industry Awards
April 11, 2017
Source
Maryland Tech Council
Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger
April 6, 2017
Source
Benzinga
Altimmune nabs $120.2 million federal contract for nasal spray anthrax vaccine
August 10, 2016
Source
Washington Business Journal
BARDA awards Altimmune anthrax contract
August 1, 2016
Source
BioCentury
Altimmune wins $120M BARDA contract to advance nasal spray anthrax vaccine
August 1, 2016
Source
FiercePharma
 

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC

Email: arr@lifesciadvisors.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe